| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Katalin Mikecz | Q30528134 |
| Tímea Besenyei | Q81349108 | ||
| Judit Laki | Q42608110 | ||
| P2093 | author name string | Tibor T Glant | |
| Zoltán Szekanecz | |||
| Júlia Kurkó | |||
| P2860 | cites work | Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls | Q24628710 |
| Genome-wide searching of rare genetic variants in WTCCC data | Q24631272 | ||
| TRAF1-C5 as a risk locus for rheumatoid arthritis--a genomewide study | Q24657292 | ||
| Gene expression profiling in murine autoimmune arthritis during the initiation and progression of joint inflammation | Q24803617 | ||
| Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis | Q28183279 | ||
| Anti-citrullinated protein/peptide autoantibodies in association with genetic and environmental factors as indicators of disease outcome in rheumatoid arthritis | Q28244317 | ||
| Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci | Q28281906 | ||
| The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis | Q28306666 | ||
| Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins | Q31460983 | ||
| The value of animal models in predicting genetic susceptibility to complex diseases such as rheumatoid arthritis | Q33458893 | ||
| Different patterns of associations with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in the extended major histocompatibility complex region | Q33868008 | ||
| Peripheral blood gene expression patterns discriminate among chronic inflammatory diseases and healthy controls and identify novel targets | Q33869998 | ||
| A gene-environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis | Q33982255 | ||
| EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs | Q34110066 | ||
| Environmental risk factors differ between rheumatoid arthritis with and without auto-antibodies against cyclic citrullinated peptides | Q34569421 | ||
| Genome-wide association study of genetic predictors of anti-tumor necrosis factor treatment efficacy in rheumatoid arthritis identifies associations with polymorphisms at seven loci | Q34886162 | ||
| Association of a single-nucleotide polymorphism in CD40 with the rate of joint destruction in rheumatoid arthritis | Q35062220 | ||
| Methotrexate related adverse effects in patients with rheumatoid arthritis are associated with the A1298C polymorphism of the MTHFR gene | Q35553306 | ||
| Proteoglycan-induced arthritis: immune regulation, cellular mechanisms, and genetics | Q35570852 | ||
| Epidemiology of adult rheumatoid arthritis | Q36095154 | ||
| Understanding the genetic contribution to rheumatoid arthritis | Q36101629 | ||
| Mechanisms of disease: Genetic susceptibility and environmental triggers in the development of rheumatoid arthritis | Q36577538 | ||
| Smoking as a trigger for inflammatory rheumatic diseases | Q36672505 | ||
| Associations between FCGR3A polymorphisms and susceptibility to rheumatoid arthritis: a metaanalysis | Q82245702 | ||
| Fcγ receptor type IIIA polymorphism influences treatment outcomes in patients with rheumatoid arthritis treated with rituximab | Q83519037 | ||
| A regulatory variant in CCR6 is associated with rheumatoid arthritis susceptibility | Q84190342 | ||
| New classification of the shared epitope in rheumatoid arthritis: impact on the production of various anti-citrullinated protein antibodies | Q84916827 | ||
| Anti-citrullinated protein antibodies in rheumatoid arthritis: as good as it gets? | Q37083378 | ||
| Pharmacogenetics of etanercept in rheumatoid arthritis | Q37235634 | ||
| Smoking and inflammatory diseases | Q37333118 | ||
| Gene expression profiles of systemic lupus erythematosus and rheumatoid arthritis | Q37754668 | ||
| Genetics of rheumatoid arthritis: time for a change! | Q37856138 | ||
| Pathophysiology of rheumatoid arthritis | Q37856146 | ||
| An overview on the genetic of rheumatoid arthritis: a never-ending story | Q37872396 | ||
| Genetics of rheumatoid arthritis: what have we learned? | Q37873802 | ||
| Pharmacogenetics: implications for therapy in rheumatic diseases | Q37913989 | ||
| Chemokine and chemokine receptor blockade in arthritis, a prototype of immune-mediated inflammatory diseases. | Q37943107 | ||
| Precipitating and perpetuating factors of rheumatoid arthritis immunopathology: linking the triad of genetic predisposition, environmental risk factors and autoimmunity to disease pathogenesis | Q37964307 | ||
| Association of STAT4 rs7574865 polymorphism with autoimmune diseases: a meta-analysis | Q38020141 | ||
| The contribution of HLA to rheumatoid arthritis. | Q38695243 | ||
| Switching between anti-tumour necrosis factors: trying to get a handle on a complex issue | Q42409891 | ||
| Associations of HLA-shared epitope, anti-citrullinated peptide antibodies and lifestyle-related factors in Hungarian patients with rheumatoid arthritis: data from the first Central-Eastern European cohort. | Q42608031 | ||
| Quantitative heritability of anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis. | Q42616461 | ||
| Interaction between smoking, the shared epitope, and anti-cyclic citrullinated peptide: a mixed picture in three large North American rheumatoid arthritis cohorts | Q42621920 | ||
| Functional variants of interleukin-23 receptor gene confer risk for rheumatoid arthritis but not for systemic sclerosis | Q42625194 | ||
| Genetic background of anticyclic citrullinated peptide autoantibody production in Hungarian patients with rheumatoid arthritis | Q42633268 | ||
| Very high levels of anti-citrullinated protein antibodies are associated with HLA-DRB1*15 non-shared epitope allele in patients with rheumatoid arthritis | Q42635006 | ||
| Fine specificity of the anti-citrullinated protein antibody response is influenced by the shared epitope alleles. | Q42638404 | ||
| Protection against anti-citrullinated protein antibody-positive rheumatoid arthritis is predominantly associated with HLA-DRB1*1301: a meta-analysis of HLA-DRB1 associations with anti-citrullinated protein antibody-positive and anti-citrullinated pr | Q42647972 | ||
| New classification of HLA-DRB1 alleles supports the shared epitope hypothesis of rheumatoid arthritis susceptibility | Q42653008 | ||
| Gene-environment interaction influences the reactivity of autoantibodies to citrullinated antigens in rheumatoid arthritis | Q42874449 | ||
| The C677T mutation in the methylenetetrahydrofolate reductase gene: a genetic risk factor for methotrexate-related elevation of liver enzymes in rheumatoid arthritis patients | Q43800679 | ||
| Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins | Q44687984 | ||
| Protein tyrosine phosphatase gene C1858T allele confers risk for rheumatoid arthritis in Hungarian subjects | Q45129416 | ||
| Contribution of common polymorphisms in reduced folate carrier and gamma-glutamylhydrolase to methotrexate polyglutamate levels in patients with rheumatoid arthritis | Q45163406 | ||
| Contribution of PTPN22 1858T, TNFRII 196R and HLA-shared epitope alleles with rheumatoid factor and anti-citrullinated protein antibodies to very early rheumatoid arthritis diagnosis. | Q46555455 | ||
| Disease-associated qualitative and quantitative trait loci in proteoglycan-induced arthritis and collagen-induced arthritis | Q47762574 | ||
| The MDR1 3435 polymorphism in patients with rheumatoid arthritis. | Q53882628 | ||
| Peripheral blood gene expression and IgG glycosylation profiles as markers of tocilizumab treatment in rheumatoid arthritis. | Q54316507 | ||
| HLA-DR genotypes in familial rheumatoid arthritis: increased frequency of protective and neutral alleles in a multicase family. | Q54628128 | ||
| Association of Anti–Cyclic citrullinated peptide antibody levels with PADI4 haplotypes in early rheumatoid arthritis and with shared epitope alleles in very late rheumatoid arthritis | Q57330799 | ||
| IL-1B and IL-1RN gene polymorphisms in rheumatoid arthritis: relationship with protein plasma levels and response to therapy | Q57753823 | ||
| The HLA–DRB1 shared epitope alleles differ in the interaction with smoking and predisposition to antibodies to cyclic citrullinated peptide | Q57788778 | ||
| Are ACPA-positive and ACPA-negative RA the same disease? | Q58234813 | ||
| “Homozygosity” for the HLA–DR shared epitope contributes the highest risk for rheumatoid arthritis concordance in identical twins | Q60692475 | ||
| Proteoglycan-induced arthritis in balb/c mice | Q61658728 | ||
| Pharmacogenetics in the rheumatic diseases, from prêt-à-porter to haute couture | Q80167171 | ||
| Associations between serum anti-CCP antibody, rheumatoid factor levels and HLA-DR4 expression in Hungarian patients with rheumatoid arthritis | Q80774573 | ||
| P433 | issue | 2 | |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| P304 | page(s) | 170-179 | |
| P577 | publication date | 2013-10-01 | |
| P1433 | published in | Clinical Reviews in Allergy & Immunology | Q1932354 |
| P1476 | title | Genetics of rheumatoid arthritis - a comprehensive review | |
| P478 | volume | 45 |
| Q64123163 | A novel nonsense variant in SUPT20H gene associated with Rheumatoid Arthritis identified by Whole Exome Sequencing of multiplex families |
| Q89909410 | Anti-CCL22 increases regulatory T cells in CD4+ T cells of rheumatoid arthritis patients via STAT5 pathway |
| Q38368437 | Are programmed cell death 1 gene polymorphisms correlated with susceptibility to rheumatoid arthritis?: A meta-analysis |
| Q34447782 | Assessment of protein tyrosine phosphatases number 22 polymorphism prevalence among rheumatoid arthritis patients: A study on Iranian patients |
| Q37523537 | Assessment of the -174G/C (rs1800795) and -572G/C (rs1800796) Interleukin 6 Gene Polymorphisms in Egyptian Patients with Rheumatoid Arthritis |
| Q90040774 | Association Between STAT4 rs7574865 Polymorphism and Rheumatoid Arthritis: Debate Unresolved |
| Q33912561 | Association between interleukin-6 gene polymorphisms and rheumatoid arthritis in Chinese Han population: a case-control study and a meta-analysis |
| Q48330739 | Association of MICA-129 polymorphism and circulating soluble MICA level with rheumatoid arthritis in a south Indian Tamil population |
| Q90388967 | Association of TRAF1/C5 Locus Polymorphisms with Epilepsy and Clinical Traits in Mexican Patients with Neurocysticercosis |
| Q36273637 | Associations between C677T and A1298C polymorphisms of MTHFR and susceptibility to rheumatoid arthritis: a systematic review and meta-analysis |
| Q47321591 | Associative role of HLA-DRB1 SNP genotypes as risk factors for susceptibility and severity of rheumatoid arthritis: A North-east Indian population-based study. |
| Q38211189 | Autoimmunity in 2013. |
| Q49334627 | BAYESIAN LARGE-SCALE MULTIPLE REGRESSION WITH SUMMARY STATISTICS FROM GENOME-WIDE ASSOCIATION STUDIES. |
| Q58574854 | Beyond autoantibodies: Biological roles of human autoreactive B cells in rheumatoid arthritis revealed by RNA-sequencing |
| Q38350065 | CD24: from a Hematopoietic Differentiation Antigen to a Genetic Risk Factor for Multiple Autoimmune Diseases |
| Q35645491 | Circulating anti-citrullinated peptide antibodies, cytokines and genotype as biomarkers of response to disease-modifying antirheumatic drug therapy in early rheumatoid arthritis |
| Q36192435 | Complicating autoimmune diseases in myasthenia gravis: a review |
| Q38762672 | Constrained Cyclic Peptides as Immunomodulatory Inhibitors of the CD2:CD58 Protein-Protein Interaction |
| Q89186811 | Effects and safety of Sinomenine in treatment of rheumatoid arthritis contrast to methotrexate: a systematic review and Meta-analysis |
| Q59100540 | Effects of thapsigargin on the proliferation and survival of human rheumatoid arthritis synovial cells |
| Q64066213 | Electrochemical Biosensors as Potential Diagnostic Devices for Autoimmune Diseases |
| Q38565478 | Epigenetics and Primary Biliary Cirrhosis: a Comprehensive Review and Implications for Autoimmunity |
| Q35102634 | Epigenetics in the pathogenesis of rheumatoid arthritis |
| Q48562919 | Evaluation of the association of UBASH3A and SYNGR1 with rheumatoid arthritis and disease activity and severity in Han Chinese |
| Q35892485 | Expression of VSTM1-v2 Is Increased in Peripheral Blood Mononuclear Cells from Patients with Rheumatoid Arthritis and Is Correlated with Disease Activity |
| Q38813384 | Family history of rheumatoid arthritis: an old concept with new developments |
| Q38388421 | Fingerprinting of anti-citrullinated protein antibodies (ACPA): specificity, isotypes and subclasses |
| Q41684414 | Food and Sex-Related Impacts on the Pharmacokinetics of a Single-Dose of Ginsenoside Compound K in Healthy Subjects |
| Q49917457 | Gastrointestinal and Hepatic Disease in Rheumatoid Arthritis |
| Q64111747 | Gene expression analysis of vascular pathophysiology related to anti-TNF treatment in rheumatoid arthritis |
| Q93147930 | Gene expression of Interleukin-18 in rheumatoid arthritis patients on disease modifying anti-rheumatic drug therapy |
| Q47563245 | Genetic and environmental risk factors for rheumatoid arthritis |
| Q87955785 | Genetic and epigenetic influences on the loss of tolerance in autoimmunity |
| Q38957340 | Genetic markers as therapeutic target in rheumatoid arthritis: A game changer in clinical therapy? |
| Q39295277 | Genetic risk scores and number of autoantibodies in patients with rheumatoid arthritis |
| Q50674763 | Genome-wide DNA methylation analysis of articular chondrocytes identifies TRAF1, CTGF, and CX3CL1 genes as hypomethylated in osteoarthritis. |
| Q53752576 | HLA DRB1/DQB1 alleles and DRB1-DQB1 haplotypes and the risk of rheumatoid arthritis in Tunisians: a population-based case-control study. |
| Q53261370 | HLA-DRB1 gene polymorphisms and its associations with rheumatoid arthritis in Chinese Han women of Shaanxi province, northwest of China. |
| Q40607323 | HLA-DRB1 the notorious gene in the mosaic of autoimmunity |
| Q45971268 | Hepatic Proteins and Inflammatory Markers in Rheumatoid Arthritis Patients. |
| Q38657171 | Human Leukocyte Antigen-Disease Associations in Rheumatoid Arthritis |
| Q92310953 | IL-7R gene polymorphisms among patients with rheumatoid arthritis: A case-control study |
| Q49439284 | IL1F7 Gene Polymorphism Is not Associated with Rheumatoid Arthritis Susceptibility in the Northern Chinese Han Population: A Case-Control Study |
| Q34123559 | Identification of myeloid-derived suppressor cells in the synovial fluid of patients with rheumatoid arthritis: a pilot study |
| Q26769061 | Identification of rheumatoid arthritis biomarkers based on single nucleotide polymorphisms and haplotype blocks: A systematic review and meta-analysis |
| Q92068746 | Individualized Drug Repositioning For Rheumatoid Arthritis Using Weighted Kolmogorov-Smirnov Algorithm |
| Q34587358 | Lack of association of matrix metalloproteinase-3 gene polymorphism with susceptibility to rheumatoid arthritis: a meta-analysis |
| Q35110153 | Lipid peroxidation-mediated inflammation promotes cell apoptosis through activation of NF-κB pathway in rheumatoid arthritis synovial cells |
| Q22252398 | Lyme disease: A rigorous review of diagnostic criteria and treatment |
| Q41388881 | MHC2TA and FCRL3 genes are not associated with rheumatoid arthritis in Mexican patients. |
| Q58549284 | Mixed-effects association of single cells identifies an expanded effector CD4 T cell subset in rheumatoid arthritis |
| Q92546075 | Multi-dimensional analysis identified rheumatoid arthritis-driving pathway in human T cell |
| Q38434277 | Multicentric reticulohistiocytosis: a critical review |
| Q36464468 | Non-MHC risk alleles in rheumatoid arthritis and in the syntenic chromosome regions of corresponding animal models |
| Q39151076 | Novel drug delivery of dual acting prodrugs of hydroxychloroquine with aryl acetic acid NSAIDs: Design, kinetics and pharmacological study |
| Q37635735 | Of mice and men: how animal models advance our understanding of T-cell function in RA. |
| Q43861706 | Optic nerve and retinal features in uveitis associated with juvenile systemic granulomatous disease (Blau syndrome). |
| Q34105680 | Peptidylarginine deiminase 4 contributes to tumor necrosis factor α-induced inflammatory arthritis |
| Q39432157 | Personalized medicine in rheumatology: the paradigm of serum autoantibodies |
| Q35614201 | Pim-2/mTORC1 Pathway Shapes Inflammatory Capacity in Rheumatoid Arthritis Synovial Cells Exposed to Lipid Peroxidations |
| Q30623992 | RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKL |
| Q26747512 | Rheumatoid Arthritis: The Stride from Research to Clinical Practice |
| Q87726283 | Rheumatoid arthritis |
| Q26824670 | Rheumatoid arthritis susceptibility genes: An overview |
| Q36673061 | Rheumatoid arthritis vaccine therapies: perspectives and lessons from therapeutic ligand epitope antigen presentation system vaccines for models of rheumatoid arthritis |
| Q38402766 | Risk of cardiovascular disease among patients with sarcoidosis: a population-based retrospective cohort study, 1976-2013. |
| Q39283898 | Role of citrullination modification catalyzed by peptidylarginine deiminase 4 in gene transcriptional regulation. |
| Q39272815 | TIM-1 rs41297579 G>A (-1454) and TIM-4 rs7700944 gene polymorphisms as possible risk factor for rheumatoid arthritis: relation to activity and severity. |
| Q37696240 | TNFAIP3 gene rs10499194, rs13207033 polymorphisms decrease the risk of rheumatoid arthritis |
| Q42004462 | TWEAK/Fn14 Axis-Targeted Therapeutics: Moving Basic Science Discoveries to the Clinic |
| Q47895288 | The 3'-UTR (CA)n microsatellite on CD40LG gene as a possible genetic marker for rheumatoid arthritis in Mexican population: impact on CD40LG mRNA expression |
| Q92662245 | The Potential Role of Genomic Medicine in the Therapeutic Management of Rheumatoid Arthritis |
| Q39098238 | The challenge of treating orphan disease |
| Q37636112 | The effects of gene polymorphisms in interleukin-4 and interleukin-6 on the susceptibility of rheumatoid arthritis in a Chinese population |
| Q40867605 | The functional PTPN22 C1858T polymorphism confers risk for rheumatoid arthritis in patients from Central Mexico |
| Q33591346 | Three single nucleotide polymorphisms of TNFAIP3 gene increase the risk of rheumatoid arthritis |
| Q46941311 | Unique topics and issues in rheumatology and clinical immunology |
| Q26772312 | Xenobiotics and loss of tolerance in primary biliary cholangitis |
| Q52850371 | [Treat to target and personalized medicine (precision medicine)]. |
Search more.